Susan Novales
Adult Health · Elmhurst, NYNPI 1104904275
Payments from drug & device makers
Across 322 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$624
- Collegium Pharmaceutical, Inc.$452
- Boehringer Ingelheim$383
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$335
- Pfizer$260
- plus $3K from 33 others
What the payments were for
- Food & beverage$6,366100%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,387 in reported general payments places this provider in the 90th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 88 | $145,134 |
| Xtampza ErOxycodone Myristate | 44 | $57,766 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 153 | $38,454 |
| NucyntaTapentadol Hcl | 24 | $32,627 |
| Oxymorphone Hcl ErOxymorphone Hcl | 13 | $28,428 |
| JardianceEmpagliflozin | 22 | $25,346 |
| BelbucaBuprenorphine Hcl | 26 | $24,780 |
| MovantikNaloxegol Oxalate | 39 | $15,739 |
| EliquisApixaban | 19 | $13,423 |
| Morphine Sulfate ErMorphine Sulfate | 174 | $13,017 |
| Fentanyl | 107 | $11,920 |
| Oxycodone Hcl | 253 | $10,143 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 286 | $9,738 |
| Hydromorphone Hcl | 139 | $8,171 |
| FarxigaDapagliflozin Propanediol | 12 | $7,829 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Belbuca | $452 | $115,17294 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate | $43 | $42,123230 claims |
| Boehringer IngelheimJardiance | $383 | $25,34622 claims |
| Redhill Biopharma Inc.Movantik | $115 | $15,73939 claims |
| PfizerEliquis | $260 | $13,42319 claims |
| AstraZenecaFarxiga | $209 | $7,82912 claims |
| AbbVieSynthroid | $1,406 | $74114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,828 adult health providers in New York.
Other adult health in Elmhurst
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.